Search hospitals > British Columbia > VANCOUVER
BCCA - Vancouver Cancer Centre
Claim this profileVANCOUVER, British Columbia V5Z 4E6
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
539 reported clinical trials
40 medical researchers
Summary
BCCA - Vancouver Cancer Centre is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Breast Cancer, Cancer, Prostate Cancer, Lung Cancer, Tumors and other specialties. BCCA - Vancouver Cancer Centre is involved with conducting 539 clinical trials across 327 conditions. There are 40 research doctors associated with this hospital, such as Zahi Mitri, Rebecca Harrison, MD, Anna Tinker, and Kerry Savage, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Zahi MitriOHSU Knight Cancer Institute1 year of reported clinical research
Expert in Breast Cancer
Studies Cancer
15 reported clinical trials
37 drugs studied
Rebecca Harrison, MDBC Cancer - The Vancouver Center6 years of reported clinical research
Studies Brain Tumor
Studies Nervous System Tumors
6 reported clinical trials
13 drugs studied
Anna TinkerBC Cancer Vancouver1 year of reported clinical research
Studies Ovarian Tumors
Studies Ovarian Cancer
6 reported clinical trials
16 drugs studied
Kerry Savage, MDBCCA - Vancouver Cancer Centre7 years of reported clinical research
Studies Lymphoma
Studies Hodgkin's Lymphoma
5 reported clinical trials
13 drugs studied
Clinical Trials running at BCCA - Vancouver Cancer Centre
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Lymphoma
Ovarian Cancer
Solid Tumors
Endometrial Cancer
Colorectal Cancer
Pancreatic Cancer
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Inavolisib + Fulvestrant vs Alpelisib + Fulvestrant
for Breast Cancer
This trial is testing two drug combinations to find out which one is better for treating a specific type of advanced breast cancer that hasn't responded to previous treatments. The drugs work by stopping cancer cells from growing and spreading.
Recruiting2 awards Phase 310 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at BCCA - Vancouver Cancer Centre?
BCCA - Vancouver Cancer Centre is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Breast Cancer, Cancer, Prostate Cancer, Lung Cancer, Tumors and other specialties. BCCA - Vancouver Cancer Centre is involved with conducting 539 clinical trials across 327 conditions. There are 40 research doctors associated with this hospital, such as Zahi Mitri, Rebecca Harrison, MD, Anna Tinker, and Kerry Savage, MD.
Where is BCCA - Vancouver Cancer Centre located?
To reach the BC Cancer Agency in Vancouver by public transit, take the SkyTrain to Broadway-City Hall Station, then transfer to bus #99 B-Line towards UBC. Exit the bus at West 10th Avenue and Ash Street. For those driving, the address is 600 W 10th Ave, Vancouver, BC, with parking available via Ash Street at the corner of West 10th Avenue.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance queries related to cancer treatment in British Columbia, patients can contact the Canadian Cancer Society's Travel Treatment Fund at 1-888-939-3333 for financial grants and travel support. The BC Cancer Agency offers several financial support programs for cancer patients, such as the Financial Support Drug Program (FSDP), BC Palliative Care Benefits Program, and Additional Financial Resources for Patients. For more personalized assistance, the Patient and Family Counselling Department at the nearest Cancer Centre is available for contact.
What insurance does BCCA - Vancouver Cancer Centre accept?
**Insurance and Coverage at BCCA - Vancouver Cancer Centre:**
- The BCCA - Vancouver Cancer Centre accepts a wide range of insurance plans, including commercial insurance, Medicare, Medicare Part C, some Medicaid, U.S. Department of Veterans Affairs, and TRICARE plans.
- In British Columbia, the Medical Services Plan (MSP) covers necessary medical services, certain dental and oral surgeries, eye examinations, orthodontic services, diagnostic services, and supplementary benefits from other health care practitioners.
- PharmaCare supports approved medications and medical supplies, while the Interim Federal Health Program offers limited coverage for protected persons without provincial or territorial health insurance.
What awards or recognition has BCCA - Vancouver Cancer Centre received?
The BC Cancer Research Institute, in partnership with the University of British Columbia, stands at the forefront of cancer research and care in British Columbia, Canada. Offering a comprehensive cancer control program alongside regional health authorities, the institute is dedicated to enhancing cancer care through a multifaceted research approach. This includes basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and the creation of new technologies and interventions, supported by over sixty labs and numerous renowned scientists across the region.